InterCure Ltd. (INCR.TA)
- Previous Close
992.30 - Open
992.30 - Bid --
- Ask 962.50 x 1676700
- Day's Range
971.00 - 1,006.00 - 52 Week Range
395.00 - 1,049.00 - Volume
161,024 - Avg. Volume
244,188 - Market Cap (intraday)
455.681M - Beta (5Y Monthly) 0.24
- PE Ratio (TTM)
21.74 - EPS (TTM)
0.46 - Earnings Date Apr 1, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
26.44
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.
www.intercure.co370
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: INCR.TA
Performance Overview: INCR.TA
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: INCR.TA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: INCR.TA
Valuation Measures
Market Cap
453.56M
Enterprise Value
513.56M
Trailing P/E
21.74
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.11
Price/Book (mrq)
0.90
Enterprise Value/Revenue
1.24
Enterprise Value/EBITDA
19.88
Financial Highlights
Profitability and Income Statement
Profit Margin
5.04%
Return on Assets (ttm)
1.12%
Return on Equity (ttm)
3.38%
Revenue (ttm)
414.79M
Net Income Avi to Common (ttm)
20.9M
Diluted EPS (ttm)
0.46
Balance Sheet and Cash Flow
Total Cash (mrq)
102.84M
Total Debt/Equity (mrq)
30.86%
Levered Free Cash Flow (ttm)
--
Research Analysis: INCR.TA
Company Insights: INCR.TA
INCR.TA does not have Company Insights